Cholesterol-lowering drugs show potential to reduce heart disease in sleep apnea patients
Check a calcium CT score first
Related Articles
Contents | Science 376, 6600
COVER Humanity’s actions have committed us to a warming climate and limited our options for mitigation. Although there is no turning back, some paths are…
404 – Not Found – Professional Heart Daily | American Heart Association
Page Not Found We’re sorry, but this page is not available. You may also be interested in: Becoming a Member Becoming a Science Volunteer Meetings…
Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes – BMC Medicine
Hybrid closed-loop (HCL) systems seamlessly interface continuous glucose monitoring (CGM) with insulin pumps, employing specialised algorithms and user-initiated automated insulin delivery. This study aimed to…
How common infections can spark psychiatric illnesses in children
And why many doctors do not realise it
Many mental-health conditions have bodily triggers
Psychiatrists are at long last starting to connect the dots
Anne Chang on the burden of chronic respiratory diseases in Indigenous people – The Lancet Respiratory Medicine in conversation with
Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people.
Nutrition app MyFitnessPal announces tools for GLP-1 medication
The new offerings and content will help members taking GLP-1 medications maximize nutrient intake and access medication tracking, recipes and community forums.
Fraud
It can’t be done View as Webpage Share This Email Share This Email Share This Email Latest Health News Weather IHSCM Academy of Fab’ Stuff…
Research Mental Health Professionals Shouldn’t Sleep On
Studies explore the relationship between poor sleep quality and schizophrenia, how sleep affects mania patients, and new hope for veterans.
Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved
Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved.
